ASHLEY BAXLEY: Open Payments
NPI 1023852159 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 78 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $556 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $158 |
| Otsuka America Pharmaceutical, Inc. | 9 | $156 |
| Novo Nordisk Inc | 8 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Corcept Therapeutics | 7 | $118 |
| Exact Sciences Corporation | 6 | $95 |
| AstraZeneca Pharmaceuticals LP | 6 | $85 |
| Amgen Inc. | 4 | $62 |
| Lilly USA, LLC | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
Products named: REXULTI, Kerendia, Korlym, Cologuard Collection Kit, Wegovy, UBRELVY, OTEZLA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
